$ASNS

Actelis Networks and Exaware Expand Strategic Collaboration with Signed Memorandum of Understanding to Pursue Joint Market Opportunities

Actelis Networks (OTCQB: ASNS) said it signed an MoU with Exaware Routing Ltd. effective June 16, 2026 to pursue joint sales and marketing in telecom and data center infrastructure markets. The framework follows an earlier acquisition term sheet and includes evaluating interoperability and potential integrated solutions. Actelis also amended its equity line of credit to support Nasdaq relisting efforts.

Original reporting
Published Jul 10, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 2:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Actelis Networks and Exaware Expand Strategic Collaboration with Signed Memorandum of Understanding to Pursue Joint Market Opportunities — source image
Decision brief

The 30-second read

$ASNSNeutralLow
01

Why it matters

The new MOU formalizes joint sales and marketing, interoperability evaluation, and potential integrated solutions, but does not specify contract value or binding obligations. The most actionable angle is whether this partnership accelerates commercial traction while Actelis addresses Nasdaq compliance.

02

Market read

A fresh, effective-date partnership framework can improve near-term sentiment, but traders should treat it as incremental until binding commercial outcomes or relisting milestones are disclosed.

03

What to watch

Nasdaq relisting remains the key overhang. The ELOC amendment suggests compliance pressure, so traders should watch for any further disclosures tied to listing requirements rather than partnership headlines.

Relevance 5/10Novelty 5/10Timing: today’s PR, effective June 16, 2026, with Actelis simultaneously pursuing Nasdaq relisting

Background

Actelis is OTCQB-listed and says it is working to regain Nasdaq listing; it previously had an acquisition term sheet with Exaware.

Company-level read

Ticker impact

$ASNSNeutralMedium confidence
Context

Actelis signed an MOU with Exaware to pursue joint customer opportunities while Actelis works to regain Nasdaq listing.

Expected impact

Likely modest, sentiment-driven upside with limited downside protection until binding revenue or relisting milestones are disclosed.

Evidence & confidence

The article discloses a new effective-date MOU and joint go-to-market/interoperability work, plus a separate note that Actelis amended its ELOC for Nasdaq compliance. However, it provides no financial terms, customer wins, or guaranteed transaction scope, so impact should be incremental rather than fundamental.

Market effects

Highlights ongoing consolidation and interoperability partnerships in cyber-hardened networking and open networking for telecom and data centers.

Israel-based Exaware collaboration may modestly support cross-border networking vendor sentiment, but no regional macro linkage is provided.

Limited global read-through because the disclosure lacks deal size, customers, or procurement commitments.

Counterpoint

Because the MOU is non-binding and lacks financial terms, it may not translate into revenue quickly, making the market reaction prone to fade.

Key entities

  • Actelis Networks, Inc.

    OTCQB-listed networking solutions provider seeking Nasdaq relisting and entering an MOU with Exaware.

  • Exaware Routing Ltd.

    Israel-based provider of routing, switching, and open networking platforms for telecom and data centers.

  • Tuvia Barlev

    Actelis Chairman and CEO quoted supporting the collaboration and Nasdaq objective.

  • Ronen Hovav

    Exaware CEO quoted supporting collaboration on customer engagements and market development.

Related articles

$ASNSMed

Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update

ACTELIS NETWORKS INC (ASNS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Actelis Networks Reports Second Quarter 2026 Financial Results and Provides Business Update Revenues were up 20% year over year, reaching $1.1 million in the second quarter of 2026; gross margin was 51%, compared to 32% in the second quarter of 2025 New wins across I

$CEROHighAI 8/10

Delisting of Securities from The Nasdaq Stock Market

Nasdaq said it will delist multiple issuers’ securities from the Nasdaq Stock Market, including CERo Therapeutics Holdings, Bowen Acquisition Corp, Graphjet Technology, Blue Hat Interactive Entertainment Technology, X3 Holdings Co, Captivision Inc, Actelis Networks, American Rebel Holdings, Reviva Pharmaceuticals, Alchemy Investments Acquisition Corp 1, Bitcoin Depot, Inotiv, GoHealth, Functional Brands, Sleep Number, Smart Digital Group, and REE Automotive. Most were suspended in 2025-2026 and

$LLYLow

Nektar v. Lilly: Lilly Defeats CRE Claim, But Jury Finds It Owes $90M For Breaching The Implied Covenant Of Good Faith And Fair Dealing

A federal jury ruled that Eli Lilly & Co. breached the implied covenant of good faith and fair dealing with Nektar Therapeutics, awarding Nektar $90 million in damages. The jury rejected Nektar's claim that Lilly breached the license agreement's commercially reasonable efforts (CRE) obligation. Lilly plans to appeal, arguing no liability should have been imposed. The case highlights risks in biopharma licensing agreements.

$EQNRMed

Galp Energia and Equinor Get Offshore Brazilian Oil Block

Galp Energia and Equinor have been awarded an offshore oil block in Brazil's Santos Basin. Galp will own 30% of the Rodocrosita block, with Equinor operating the remaining 70%. The companies may explore synergies with the adjacent Bacalhau project, which is ramping up production and will contribute 40,000 barrels per day to Galp once fully operational.

$PINSMed

Pinterest (PINS), Why Is It Back In The Spotlight?

Pinterest (PINS) appointed Amazon's James Dibbo as its new CFO. The company's stock has shown mixed performance, with a recent 7-day return of 7.52% but a 1-year return of -36.11%. Analysts have varying views on its valuation, with some seeing it as undervalued at $20.31 per share compared to a fair value estimate of $29.05, while others note its high P/E ratio of 46.2x.